Kajetan Juszczak Selected Research

Kajetan Juszczak Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 01/2011
10	Overactive Urinary Bladder (Overactive Bladder) 01/2022 - 01/2007
8	Urinary Bladder Neoplasms (Bladder Cancer) 02/2022 - 08/2018
2	Obesity 11/2022 - 10/2022
2	Hemorrhagic Cystitis 01/2022 - 05/2021
2	Frailty 01/2022 - 01/2020
2	Cystitis 05/2021 - 01/2007
2	Carcinogenesis 10/2019 - 06/2012
2	Hypertrophy 10/2019 - 01/2019
2	Kidney Neoplasms (Kidney Cancer) 06/2013 - 06/2012
2	Hypertension (High Blood Pressure) 01/2012 - 01/2009
1	Hypercholesterolemia 11/2022
1	Body Weight (Weight, Body) 10/2022
1	COVID-19 01/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022
1	Neoplasm Metastasis (Metastasis) 12/2021
1	Edema (Dropsy) 05/2021
1	Urinary Incontinence 10/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Malnutrition (Nutritional Deficiencies) 08/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 10/2017
1	Infections 06/2017
1	Colitis 02/2017
1	Hyperalgesia 02/2017
1	Underactive Urinary Bladder 08/2016
1	Reperfusion Injury 01/2016
1	Tachycardia (Tachyarrhythmias) 01/2014
1	Pheochromocytoma 01/2014
1	Hemorrhage 06/2013
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2012
1	Hyperplasia 01/2012
1	Male Infertility (Male Sterility) 01/2011
1	Drug-Related Side Effects and Adverse Reactions 01/2011
1	Inflammation (Inflammations) 09/2010

Drug/Important Bio-Agent (IBA)

4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2007
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2012
2	Type A Botulinum Toxins (Botox)FDA Link 01/2019 - 12/2018
2	MelatoninIBA 01/2016 - 01/2011
1	EnzymesIBA 11/2022
1	RubidiumIBA 11/2022
1	fibroblast growth factor 21IBA 11/2022
1	Indicators and Reagents (Reagents)IBA 11/2022
1	CholesterolIBA 10/2022
1	Lipoproteins (Lipoprotein)IBA 10/2022
1	LeptinIBA 10/2022
1	Cytostatic AgentsIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Mitotane (Lysodren)FDA Link 07/2021
1	asiatic acidIBA 05/2021
1	Plant ExtractsIBA 12/2020
1	hexylcaine FDA Link 02/2020
1	DimethadioneIBA 02/2020
1	Nizatidine (Axid)FDA LinkGeneric 02/2020
1	Chenodeoxycholic Acid (Chenix)FDA Link 02/2020
1	Acetaminophen (Paracetamol)FDA LinkGeneric 02/2020
1	FenoterolIBA 02/2020
1	conessineIBA 02/2020
1	Biological FactorsIBA 10/2019
1	Aromatic HydrocarbonsIBA 10/2019
1	Angiotensin IIIBA 10/2017
1	FluoroquinolonesIBA 06/2017
1	Cephalosporins (Cephalosporin Antibiotics)IBA 06/2017
1	Sulfonic AcidsIBA 02/2017
1	Analgesics (Analgesic Drugs)IBA 02/2017
1	Imatinib Mesylate (Gleevec)FDA Link 01/2014
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2014
1	Complement System Proteins (Complement)IBA 06/2013
1	TachoSilIBA 06/2013
1	Hemostatics (Antihemorrhagics)IBA 06/2013
1	Hemoglobins (Hemoglobin)IBA 01/2013
1	Protons (Proton)IBA 06/2012
1	AcidsIBA 06/2012
1	Glutathione (Reduced Glutathione)IBA 06/2012
1	Free RadicalsIBA 06/2012
1	Oxygen (Dioxygen)IBA 06/2012
1	Trace Elements (Biometals)IBA 06/2012
1	DNA (Deoxyribonucleic Acid)IBA 06/2012
1	Glutathione Disulfide (GSSG)FDA LinkGeneric 06/2012
1	Vascular Endothelial Growth Factor CIBA 01/2012
1	SaltsIBA 01/2012
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2011
1	Capsaicin (Zostrix)FDA Link 01/2011
1	Hypertonic SolutionsIBA 09/2010
1	Natriuretic PeptidesIBA 01/2009
1	KininsIBA 01/2009

Therapy/Procedure

7	Cystectomy 02/2022 - 01/2018
5	Therapeutics 01/2022 - 01/2011
4	Drug Therapy (Chemotherapy) 01/2019 - 01/2011
3	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 01/2019
2	Intravesical Administration 01/2022 - 12/2018
2	Lymph Node Excision (Lymph Node Dissection) 03/2020 - 01/2018
1	Transcranial Direct Current Stimulation 10/2022
1	Elective Surgical Procedures 01/2022
1	Nephrectomy 01/2022
1	Urinary Diversion (Ileal Conduit) 12/2021
1	Preoperative Exercise 01/2020
1	Injections 01/2019
1	Warm Ischemia 10/2011
1	Lasers (Laser) 01/2011